Evidence map›Paper›PMID 28664541›Full record

Trial reportInternational journal of methods in psychiatric research2018

Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial.

Weam Fageera, Alexandru Traicu, Sarojini M Sengupta, Marie-Eve Fortier, Zia Choudhry, Aurélie Labbe, Natalie Grizenko, Ridha Joober

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of methods in psychiatric research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Weam FageeraDouglas Mental Health University Institute, Montreal, Quebec, Canada.
Alexandru TraicuDepartment of Psychiatry, McGill University, Montreal, Quebec, Canada.
Sarojini M SenguptaDouglas Mental Health University Institute, Montreal, Quebec, Canada.
Marie-Eve FortierDouglas Mental Health University Institute, Montreal, Quebec, Canada.
Zia ChoudhryDouglas Mental Health University Institute, Montreal, Quebec, Canada.
Aurélie LabbeDepartment of Psychiatry, McGill University, Montreal, Quebec, Canada.
Natalie GrizenkoDouglas Mental Health University Institute, Montreal, Quebec, Canada.
Ridha JooberDouglas Mental Health University Institute, Montreal, Quebec, Canada.ORCID 0000-0003-3492-807X

Funding

CIHR
6 · The paper itself

Abstract

This study aims to quantify placebo response (PR) in children with attention deficit hyperactivity disorder (ADHD) as assessed by parents and teachers and to explore some of its determinants. Five hundred and forty children with ADHD (ages 6-12) were recruited to a randomized, double-blind, placebo-controlled crossover trial with methylphenidate. The main outcome variable was Conners' Global Index (CGI), based on assessment of behaviour by parents (CGI-P) and teacher (CGI-T). PR was calculated as the difference between CGI-P/T scores at baseline and placebo week. There was a highly significant PR as assessed by the parents' and teachers' (p < 0.001). The magnitude of PR as assessed by parents was greater (10.57 points) compared to that assessed by teachers (3.93 points). The determinants of PR were different between parents and teachers. For parents, income, marital status, education, maternal smoking during pregnancy, and prior psychostimulant exposure (PPE) showed a significant effect on PR. For teachers, only ethnicity and PPE had an effect. The pattern of PR revealed two distinct profiles that may shed some light on the mechanisms involved in PR. PR in children with ADHD varies depending on the setting of the observations and the evaluator. Several psychosocial factors have been identified as modulators of PR. This is relevant for the design and interpretation of clinical trials and for clinical practice.

Indexed as

Outcome Assessment, Health CarePlacebo EffectAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildCross-Over StudiesDouble-Blind MethodFemaleHumansMaleMethylphenidateParentsSchool TeachersCentral Nervous System StimulantsMethylphenidateADHDparentsplacebo responsepredictorsteachers

Identifiers

PMID28664541
PMCPMC6877247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.